Cite
APA Citation
Cunningham, D., Shamblaw, D., Zurawski, C., Robbins, W., Scarsella, A., Nguyen, T., Hindman, J., Ebrahimi, R., & Piontkowsky, D. (n.d.). 1567Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48. Open forum infectious diseases, 1, S417. http://access.bl.uk/ark:/81055/vdc_100135169939.0x00001f